secwatch.observer — SEC 8-K summary
======================================

Issuer:     DURECT CORP (—)
CIK:        0001082038
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0000950170-24-130440
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DURECT sells ALZET product line for $17.5M, pays off Oxford term loan
---------------------------------------------------------------------

- Transaction valued at $17.5M; DURECT paid off all remaining Oxford Finance LLC term loan obligations.
- Proceeds extend cash runway through first half of 2025; focus on larsucosterol Phase 3 trial for AH.
- ALZET osmotic pumps acquired by Alzet, LLC, a subsidiary of Lafayette Instrument Co. (Branford Castle portfolio).
- Transition services agreement for up to six months post-closing; Aquilo Partners acted as financial advisor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082038/000095017024130440/0000950170-24-130440-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082038/000095017024130440/drrx-20241122.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-130440

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer